marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 12-18-2024
Cyclo Therapeutics Financial Statements 2011-2024 | CYTH
Annual Financial Statements Cyclo Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
26.1 M | 9.79 M | 23.4 M | - | - | - | - | - | - | - | - | - | - |
Shares |
16.3 M | 8.44 M | 6.37 M | - | - | - | - | - | - | - | - | - | - |
Historical Prices |
1.6 | 1.16 | 3.68 | 5.92 | 19 | 79 | 32 | 47 | 49 | 70 | 9 | 12 | 13 |
Net Income |
-20.1 M | -15.5 M | -14.3 M | - | - | - | - | - | - | - | - | - | - |
Revenue |
1.08 M | 1.38 M | 1.59 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | 105 K | 133 K | 198 K | 124 K | 273 K | 426 K | 140 K | 274 K |
Gross Profit |
992 K | 1.24 M | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-20.1 M | -15.6 M | -14.3 M | -8.96 M | -7.54 M | -4.27 M | -3.84 M | -4.21 M | -2.41 M | -562 K | 337 K | 157 K | -74.3 K |
Interest Expense |
- | - | -3.4 K | - | - | - | - | 28.6 K | 31.3 K | 33.7 K | 53.9 K | 61.8 K | 25.8 K |
EBITDA |
-20 M | -15.6 M | -14.3 M | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Cyclo Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
28.6 M | 28.6 M | 28.6 M | 16.2 M | 14 M | 11 M | 8.48 M | 8.45 M | 8.42 M | 8.41 M | 8.4 M | 6.45 M | 6.37 M | 5.33 M | 4.77 M | 1.52 M | 1.37 M | 1.22 M | 1.22 M | 121 M | 101 M | 90.8 M | 90.8 M | 87.2 M | 78.9 M | 73 M | 73 M | 73 M | 72.9 M | 69.3 M | 67 M | 66.9 M | 60.8 M | 58.7 M | 58.7 M | 57.3 M | 54.5 M | 54.5 M | 54.4 M | 53.8 M | 52.1 M | 42.5 M | 37.5 M | 37.4 M | 36.9 M | 36.9 M | 36.9 M | 36.7 M | 36.6 M | 36.6 M | 36.6 M | 35.8 M | 35.5 M | 36.6 M |
Net Income |
-5.98 M | -4.34 M | - | -4.77 M | -4.64 M | -5.01 M | - | -4.25 M | -3.45 M | -2.77 M | - | -3.86 M | -3.6 M | -4.04 M | - | -8.94 M | -2.19 M | -2.63 M | - | -7.53 M | -7.53 M | -7.53 M | - | -787 K | -1.29 M | -813 K | - | -634 K | -828 K | -987 K | - | -4.22 M | -4.22 M | -4.22 M | - | 2.55 M | 2.55 M | 2.55 M | - | -221 K | -151 K | 96.9 K | - | -94.5 K | 264 K | 120 K | - | -45.7 K | -56.4 K | 45.8 K | - | -50.7 K | 35.4 K | -10.2 K |
Revenue |
123 K | 202 K | - | 495 K | 117 K | 152 K | - | 452 K | 542 K | 195 K | - | 404 K | 239 K | 358 K | - | 222 K | 210 K | 326 K | - | 286 K | 273 K | 221 K | - | 224 K | 349 K | 198 K | - | 241 K | 523 K | 305 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 167 K | 708 K | 583 K | - | 157 K | 148 K | 442 K | - | 231 K | 369 K | 254 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26 K | 16.3 K | 20.6 K | - | 13 K | 54 K | 23.7 K | - | 19.7 K | 79 K | 19.4 K | - | 30.9 K | 56.2 K | 36.8 K | - | 25.2 K | 57.4 K | 22.5 K | - | 46.4 K | 23 K | 120 K | - | 29.1 K | 146 K | 216 K | - | 23.2 K | 23.2 K | 110 K | - | 24.4 K | 178 K | 46.7 K |
Gross Profit |
110 K | 191 K | - | - | 97.2 K | 142 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.64 M | -5.12 M | - | -4.77 M | -4.63 M | -5.01 M | - | -4.25 M | -3.46 M | -2.93 M | - | -3.86 M | -3.6 M | -4.04 M | - | -1.44 M | -2.2 M | -2.64 M | - | -1.63 M | -1.37 M | -1.91 M | - | -790 K | -1.29 M | -814 K | - | -637 K | -831 K | -990 K | - | -1.61 M | -1.07 M | -733 K | - | -740 K | -352 K | -383 K | - | -198 K | -213 K | 158 K | - | -103 K | 370 K | 177 K | - | -28.6 K | -59.3 K | 76.3 K | - | -46.2 K | 40.8 K | -4.43 K |
Interest Expense |
-196 K | 238 K | - | -3.89 K | -3.51 K | 47 | - | 1.62 K | 4.03 K | 4.34 K | - | -1.24 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.97 K | 7.17 K | 7.58 K | - | 7.75 K | 7.9 K | 7.88 K | - | 8.34 K | 8.73 K | 8.49 K | - | 12.4 K | 15.2 K | 17.1 K | - | 17.1 K | 15.2 K | 13.5 K | - | 4.77 K | 7.05 K | 5.88 K |
EBITDA |
- | -5.12 M | - | - | - | -5 M | - | -4.23 M | -3.45 M | -2.93 M | - | -3.85 M | -3.59 M | -4.03 M | - | -1.43 M | -2.2 M | -2.64 M | - | -1.62 M | -1.37 M | -1.91 M | - | -782 K | -1.29 M | -812 K | - | -630 K | -826 K | -988 K | - | -1.61 M | -1.02 M | -692 K | - | -615 K | -272 K | -341 K | - | -80.6 K | -137 K | 196 K | - | -62.1 K | 405 K | 212 K | - | 7.4 K | -28.7 K | 117 K | - | -27.6 K | 53.2 K | 1.38 K |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 585 K | 387 K | 402 K | - | 270 K | 340 K | 407 K | - | 186 K | 207 K | 366 K | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency